Pathkey.AI Ltd

Company Profile

Sector

Healthcare

Industry

Health Information Services

Employees

N/A

Website

www.pathkey.ai

Country

Australia

Exchange

ASX

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs TrialGen, an AI-powered tool streamlines clinical trial design process.

The company serves biopharma, MedTech, government, and healthcare organizations. Formerly known as Opyl Limited, the company rebranded as Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.

Key Stats

52-Week Range

A$0.01A$0.07

Beta1.49

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.01

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.